Pascua, Annabelle .
HRN: 18-73-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2023
CEFUROXIME 1.5GM (VIAL)
09/09/2023
09/16/2023
IV
1.5g
Q8
S/P TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes